Abstract
Background: The improvement in the treatment of breast cancer is due to early diagnosis, better understanding of the natural history of this disease and therapeutic improvements over the years. There is a gradual shift away from radical surgery advocated by Halsted to the breast conservative surgery during the last few decades all over the world mainly influenced by the results of several large trials of lesser surgical procedures.
 Methods: Hospital based descriptive study was conducted on patients with Early Breast Cancer presenting to the Department of General Surgery in Guru Gobind Singh Medical College & Hospital, Faridkot.
 Results: Mean blood loss of the subjects of the BCS group was observed to be 44.07±15.76 ml as compared to 94.36 ± 31.50 ml in the subjects of the MRM. Mean operative time of the subjects of the BCS group was observed to be 46.03±8.68 minutes as compared to the mean operative time of 64.03±16.56 minutes in the subjects of the MRM group. Mean VAS score on day-1 in BCS group and in MRM group was 5.3±1.98 and 6.73±1.70 respecively. Mean VAS score on day-3 in BCS group and in MRM group was 4.46±1.50 and 5.1±1.56 respectively. Mean VAS score on day-5 in BCS group and in MRM group was 2.96±0.76 and 2.96±1.06 respectively. Seroma Formation was observed in 3.33 % cases in BCS group and 16.67 % in MRM group. Flap necrosis was observed in 0 % in BCS group whereas 10.00 % of the patients had flap necrosis in MRM group. Positive margins were absent in both BCS group and MRM group. Wound infection was observed in 6.67% of the patients in the BCS group and 20.00% in the MRM group. Quality of life score for BCS and MRM was 108.53±14.62 and 95.26±14.70 respectively.
 Conclusion: Breast conservation surgery should be the preferred treatment for Stage-I and Stage-II Breast cancer disease due to its lesser post-operative pain, shorter duration of surgery, lesser blood loss and short hospital stay thus helping in early returning to normal activity. Breast conservation surgery has better outcomes compared with Modified radical mastectomy.
 Keywords: BCS, MRM, Breast surgery
Highlights
The improvement in the treatment of breast cancer is due to early diagnosis, better understanding of the natural history of this disease and therapeutic improvements over the years
There is a gradual shift away from radical surgery advocated by Halsted to the breast conservative surgery during the last few decades all over the world mainly influenced by the results of several large trials of lesser surgical procedures
Breast conservation surgery should be the preferred treatment for Stage-I and Stage-II Breast cancer disease due to its lesser post-operative pain, shorter duration of surgery, lesser blood loss and short hospital stay helping in early returning to normal activity
Summary
The improvement in the treatment of breast cancer is due to early diagnosis, better understanding of the natural history of this disease and therapeutic improvements over the years. The surgical treatment provides a reasonable chance of curing for most of the early breast cancers. Results: Mean blood loss of the subjects of the BCS group was observed to be 44.07±15.76 ml as compared to 94.36 ± 31.50 ml in the subjects of the MRM. Mean VAS score on day-5 in BCS group and in MRM group was 2.96±0.76 and 2.96±1.06 respectively. Conclusion: Breast conservation surgery should be the preferred treatment for Stage-I and Stage-II Breast cancer disease due to its lesser post-operative pain, shorter duration of surgery, lesser blood loss and short hospital stay helping in early returning to normal activity.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
